Arch Scientist Awarded CIHR Grant to Study the Role of Dipeptidase-1 in Chronic Kidney Disease
07.02.2023 - TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) - Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of innovative technologies and novel therapeutics targeting ...
Source: wallstreet-online.de